| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/30/2003 | CN1433406A BenzoÒÇöaÒÇòphenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and Ôàí" |
| 07/30/2003 | CN1433405A Quinazoline compounds |
| 07/30/2003 | CN1433403A Solid pharmaceutical preparation |
| 07/30/2003 | CN1433396A Pharmaceutical compounds |
| 07/30/2003 | CN1433320A Carbonyl stress-ameliorating agents |
| 07/30/2003 | CN1433317A Use of immunosuppessant for increasing antifungal activity of lipopetide |
| 07/30/2003 | CN1433316A Biologically active agents and drugs |
| 07/30/2003 | CN1433315A Radioprotecting agent |
| 07/30/2003 | CN1433313A Combination of serotonin reuptake inhibitor and 5-HT2C antagonist, inverse agonist or partial agonist |
| 07/30/2003 | CN1433312A Barbituric acid analogs as therapeutic agents |
| 07/30/2003 | CN1433311A Methods for making sustained release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 07/30/2003 | CN1433309A Dual-release compositions of cyclooxygenase-2-inhibitor |
| 07/30/2003 | CN1433307A Prostaglandin compounds for treating congestive heart failure |
| 07/30/2003 | CN1433303A Use of fumaric acid derivatives for treating mitochondrial diseases |
| 07/30/2003 | CN1432369A Lubricant liquid for human genitals |
| 07/30/2003 | CN1432362A Oral Nimoldipine prepn and its prepn process |
| 07/30/2003 | CN1432357A Fever allaying prepn containing xylitol |
| 07/30/2003 | CN1116288C Urea derivatives as inhibitors of inosine-5'-phospho-dehydrogenase |
| 07/30/2003 | CN1116287C Diphenyl heterocycles as potassium channel modulators |
| 07/30/2003 | CN1116286C 4-anilinoquinazoline derivatives |
| 07/30/2003 | CN1116283C Cyanoguanidines as well proliferation inhibitors |
| 07/30/2003 | CN1116282C Bisulfate salt of HIV protease inhibitor |
| 07/30/2003 | CN1116067C Soft intelligence growth promoting capsule and its preparation method |
| 07/30/2003 | CN1116058C Chinese-medicinal plaster for treating spontaneousor night sweating and its preparing process |
| 07/30/2003 | CN1116041C Hernia treating medicine |
| 07/30/2003 | CN1116039C Molecular dispersion composition with enhanced bioavailability |
| 07/30/2003 | CA2369711A1 Macrocyclic peptides active against the hepatitis c virus |
| 07/29/2003 | WO2004065614A2 Suppression of cytotoxic protein conformers |
| 07/29/2003 | US6600059 Protecting cells from injury due to intrinsic membrane lysis, oxidation and/or invasion by destructive agents. Even more particularly, the present invention provides compositions and methods for treating or prophylactically inhibiting |
| 07/29/2003 | US6600052 With a ring cyclizing reagent to form the compound of Formula V to yield a compound of Formula V: inhibitors of the cyclooxygenase- II enzyme. and antiinflammatory agents and analgesic pharmaceutical agents. |
| 07/29/2003 | US6600038 Carbamoyl tetrahydropyridine derivatives |
| 07/29/2003 | US6600037 4,5-disubstituted-2-aminopyrimidines |
| 07/29/2003 | US6600036 Treating diseases of the central nervous system. |
| 07/29/2003 | US6600035 6-(substituted methylene) penems and intermediates |
| 07/29/2003 | US6600030 Nucleotide sequences which code binding protein for use in diagnosis and treatment of asthma, arthritis, Crohn's and Grave's diseases and cystic fibrosis |
| 07/29/2003 | US6600015 Treatment or prevention of obesity. |
| 07/29/2003 | US6599943 Preventive treatment, related to the radical generating nature of the xanthine dehydrogenase/xanthine oxidase |
| 07/29/2003 | US6599938 Optionally substituted Schiff base condensation products comprising an amino acid component and a benzaldehyde component, that have MIF (macrophage migration inhibitory factor) antagonist activity |
| 07/29/2003 | US6599929 1H-indole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 07/29/2003 | US6599926 Anticoagulant agents for treatment and prevention of thromboembolic disorders |
| 07/29/2003 | US6599925 Cardiovascular disorders; anticancer agents |
| 07/29/2003 | US6599923 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action |
| 07/29/2003 | US6599919 Administering reversible competitive inhibitor of enzyme in an amount effective to enhance activity of enzyme in cell |
| 07/29/2003 | US6599918 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans |
| 07/29/2003 | US6599917 A squalene-synthesizing enzyme inhibitor, a cholesterol biosynthesis inhibitor and a triglyceride biosynthesis inhibitor |
| 07/29/2003 | US6599912 Methods and compositions for modulating cell proliferation and cell death |
| 07/29/2003 | US6599910 Substituted triazole compounds |
| 07/29/2003 | US6599904 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
| 07/29/2003 | US6599901 Pyridone substituted benzothiazole derivatives |
| 07/29/2003 | US6599900 1-oxa-3,9-diaza-spiro[5,5]undecan-2-ones |
| 07/29/2003 | US6599894 Competitive inhibitors of trypsin-like proteases, such as thrombin, and in treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants |
| 07/29/2003 | US6599742 Antisense oligonucleotide inhibition of human serine/threonine protein phosphatase gene expression |
| 07/29/2003 | US6599706 Recombinant PR-3 and assays employing the same |
| 07/29/2003 | US6599627 Microencapsulation of drugs by solvent exchange |
| 07/29/2003 | US6599537 Antiradical, cytophotoprotective, tyrosinase and melanogenesis inhibiting and antiprotease effects |
| 07/29/2003 | US6599536 Therapy of estrogen-associated disorders |
| 07/29/2003 | US6599530 Oral compacted composition comprising catechol derivatives |
| 07/29/2003 | US6599528 Mechanically stable pharmaceutical presentations form containing liquid or semisolid surface-active substances |
| 07/29/2003 | US6599507 Composition for the treatment of immune deficiencies and methods for its preparation and use |
| 07/29/2003 | US6599506 Inhibiting integrin-associated diseases; rejection of transplanted organs, allergies, and autoimmune diseases |
| 07/29/2003 | US6599501 Immunomodulators |
| 07/29/2003 | US6599499 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 07/29/2003 | CA2473102A1 Suppression of cytotoxic protein conformers |
| 07/29/2003 | CA2268437C Naringin and naringenin as 3-hydroxy-3-methylglutaryl coa(hmg-coa) reductase inhibitor |
| 07/29/2003 | CA2244621C 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor antagonists |
| 07/29/2003 | CA2210444C Keratinocyte growth factor-2 |
| 07/29/2003 | CA2188690C Selective thrombin inhibitors |
| 07/29/2003 | CA2188030C Use of bisphophonates for inhibiting bone resorption following implantation of orthopedic prosthesis |
| 07/29/2003 | CA2185036C Use of a non photosynthetic filamentous bacteria extract and composition containing the same |
| 07/29/2003 | CA2180119C The composition containing snapping turtle and tortoise, the preparation and the use thereof |
| 07/29/2003 | CA2094280C A method for transplanting cells into the brain and therapeutic uses therefor |
| 07/29/2003 | CA2056065C Preparation of 3-alkylated indoles |
| 07/28/2003 | CA2398226A1 Increased-dosage nelfinavir tablet and method of making same |
| 07/24/2003 | WO2003060521A2 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 07/24/2003 | WO2003060475A2 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues |
| 07/24/2003 | WO2003060468A2 Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease |
| 07/24/2003 | WO2003060091A2 Selective melanin-concentrating hormone type -1 receptor agonists |
| 07/24/2003 | WO2003060090A2 Novel cytokine zcytor17 ligand |
| 07/24/2003 | WO2003060085A2 Mammalian neural stem cells, compositions and uses thereof |
| 07/24/2003 | WO2003060082A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 07/24/2003 | WO2003060080A2 Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| 07/24/2003 | WO2003059950A1 Ifnar2 mutants, their production and use |
| 07/24/2003 | WO2003059942A2 Peptides and peptidomimetics having anti-proliferative activity and their use |
| 07/24/2003 | WO2003059921A1 Mmp inhibitors |
| 07/24/2003 | WO2003059913A1 Roh-kinase inhibitors |
| 07/24/2003 | WO2003059912A1 Oxothieno (3, 2-b) pyridinecarboxamides as antiviral agents |
| 07/24/2003 | WO2003059911A2 4-OXO-4, 7-DIHYDROFURO[2,3-b]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS |
| 07/24/2003 | WO2003059907A1 Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof |
| 07/24/2003 | WO2003059905A1 Pyrrolidone carboxamides |
| 07/24/2003 | WO2003059900A1 Coumarin derivatives, process for their production and use thereof |
| 07/24/2003 | WO2003059899A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof |
| 07/24/2003 | WO2003059898A2 Eponemycin and epoxomicin analogs and uses thereof |
| 07/24/2003 | WO2003059891A1 Substituted pyridazinones as inhibitors of p38 |
| 07/24/2003 | WO2003059889A1 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 07/24/2003 | WO2003059886A1 Acyl sulfonamide derivative |
| 07/24/2003 | WO2003059885A1 Therapeutic acridone and acridine compounds |
| 07/24/2003 | WO2003059884A1 Modulators of lxr |
| 07/24/2003 | WO2003059883A1 (4-oxopiperidin-1-yl)benzoic acid derivatives and process for their preparation |
| 07/24/2003 | WO2003059882A1 Phenoxy piperidines for treating diseases such as schizophrenia and depression |
| 07/24/2003 | WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |